Thirty-two amenorrheic patients were treated with a tablet oral placebo preparation for a period varying from 30 to 180 days. Another 24 amenorrheic patients were also treated with a placebo administered i.m. for a period varying from 30 to 120 days. As a consequence of the treatment, 27 patients (48%) had menstrual bleedings. The progestogen withdrawal test responsive patients were more responsive to placebo (73 vs. 14% in the progestogen withdrawal test nonresponsive, p < 0.001). The time lag between starting the medication and the first bleeding varied between 4 and 120 days with a mean value of 33.9 (SD 26.3). Oral placebo was more effective than the intramuscular form (56 vs. 38%, p < 0.05)
Two studies are presented which investigated the relationship between oral contraceptives (o.c.s) an...
Placebos are widely used in clinical practice in spite of ethical restrictions. Whether such use is ...
(1) Background: Progesterone-only pills (POP) are widely used contraceptives. About 40% of women tak...
Thirty-two amenorrheic patients were treated with a tablet oral placebo preparation for a period var...
Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2 . 5 mg twice ...
Objective. To determine if a new protocol of administration of clomiphene citrate (CC) is effective ...
IntroductionRecent evidence suggests that for certain clinical conditions, placebos can improve clin...
: A clinical study of the use of medroxyprogesterone acetate as a method of contraception, administe...
Double blind randomized placebo controlled trial was conducted to evaluate the efficacy of Tranexami...
Placebo, defined as any therapeutic procedure, without any specific activity, given deliberately to ...
Aim: To assess the efficacy and safety of human placenta extract in the relief of climacteric sympto...
Placebos are widely used in clinical practice in spite of ethical restrictions. Whether such use is ...
The effects produced when presumably inert substances ( e.g., lactose and saline) are given to norma...
BackgroundHot flushes and night sweats are common symptoms experienced by menopausal women. Hormone ...
Background: Depot medroxyprogesterone acetate (DMPA), a long-acting contraceptive, has many advantag...
Two studies are presented which investigated the relationship between oral contraceptives (o.c.s) an...
Placebos are widely used in clinical practice in spite of ethical restrictions. Whether such use is ...
(1) Background: Progesterone-only pills (POP) are widely used contraceptives. About 40% of women tak...
Thirty-two amenorrheic patients were treated with a tablet oral placebo preparation for a period var...
Fourteen women with normoprolactinaemic amenorrhoea were treated with bromocriptine (2 . 5 mg twice ...
Objective. To determine if a new protocol of administration of clomiphene citrate (CC) is effective ...
IntroductionRecent evidence suggests that for certain clinical conditions, placebos can improve clin...
: A clinical study of the use of medroxyprogesterone acetate as a method of contraception, administe...
Double blind randomized placebo controlled trial was conducted to evaluate the efficacy of Tranexami...
Placebo, defined as any therapeutic procedure, without any specific activity, given deliberately to ...
Aim: To assess the efficacy and safety of human placenta extract in the relief of climacteric sympto...
Placebos are widely used in clinical practice in spite of ethical restrictions. Whether such use is ...
The effects produced when presumably inert substances ( e.g., lactose and saline) are given to norma...
BackgroundHot flushes and night sweats are common symptoms experienced by menopausal women. Hormone ...
Background: Depot medroxyprogesterone acetate (DMPA), a long-acting contraceptive, has many advantag...
Two studies are presented which investigated the relationship between oral contraceptives (o.c.s) an...
Placebos are widely used in clinical practice in spite of ethical restrictions. Whether such use is ...
(1) Background: Progesterone-only pills (POP) are widely used contraceptives. About 40% of women tak...